Shanghai Haohai Biological Tech Co (688366) — Cash Flow-to-Debt Ratio
Shanghai Haohai Biological Tech Co (688366) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥109.13 Million could theoretically repay 0% of its total liabilities (CN¥1.23 Billion) in one year. See financial agility of Shanghai Haohai Biological Tech Co to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Haohai Biological Tech Co Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Shanghai Haohai Biological Tech Co across 13 annual periods. For the full cash flow conversion analysis, see 688366 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Shanghai Haohai Biological Tech Co (2012–2024)
Year-by-year debt coverage analysis for Shanghai Haohai Biological Tech Co. Check earnings quality score of Shanghai Haohai Biological Tech Co to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.54x | CN¥648.57 Million | CN¥1.20 Billion | ▼ -7.6% |
| 2023 | 0.58x | CN¥634.45 Million | CN¥1.09 Billion | ▲ +149.6% |
| 2022 | 0.23x | CN¥231.30 Million | CN¥990.02 Million | ▼ -39.2% |
| 2021 | 0.38x | CN¥342.29 Million | CN¥890.07 Million | ▼ -17.2% |
| 2020 | 0.46x | CN¥262.07 Million | CN¥564.46 Million | ▼ -33.7% |
| 2019 | 0.70x | CN¥348.91 Million | CN¥498.52 Million | ▲ +7.5% |
| 2018 | 0.65x | CN¥391.28 Million | CN¥600.90 Million | ▲ +34.5% |
| 2017 | 0.48x | CN¥343.06 Million | CN¥708.59 Million | ▲ +34.6% |
| 2016 | 0.36x | CN¥254.49 Million | CN¥707.55 Million | ▼ -79.0% |
| 2015 | 1.72x | CN¥268.51 Million | CN¥156.48 Million | ▲ +90.6% |
| 2014 | 0.90x | CN¥141.99 Million | CN¥157.74 Million | ▼ -53.4% |
| 2013 | 1.93x | CN¥146.91 Million | CN¥76.13 Million | ▼ -10.9% |
| 2012 | 2.16x | CN¥118.42 Million | CN¥54.70 Million | — |